Skip to main content
Log in

Myocardial fibrosis and right ventricular function of heterotopically transplanted hearts in rats treated with cyclosporin

  • Part II: Cardiac Hypertrophy and Failure
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The aim was to determine whether treatment of rats with cyclosporin A (CsA) leads to deleterious side effects on heterotopically iso- or allotransplanted hearts when compared with recipient native in situ hearts. Four experimental groups were employed: inbred (Lewis) rats receiving either no immunosuppression or CsA at a dose of 15 mg.kg−1 per day for 7 days after surgery, and outbred (Wistar) rats receiving CsA at the same daily dose for either 7 or 21 days. One month following surgery, the mass of all transplanted hearts decreased and resulting atrophy was associated with relative myocardial fibrosis. Treatment with CsA significantly increased the concentration and content of collagen in the right and left ventricles of all transplanted and recipient hearts. No appreciable difference was observed between corresponding hearts of inbred and outbred groups receiving the identical dose of CsA, and between hearts in outbred groups treated for either 7 or 21 days. No signs of right ventricular mechanical dysfunction, as assessed on the isolated perfused ‘working’ preparation, were observed after CsA treatment in both transplanted and recipient hearts. The maximal steady state developed pressure (RVDevP) and the rate of its development [(+dP/dt)max] were slightly higher in transplants than in the corresponding recipients, and in CsA-treated versus untreated hearts, while the index of contractile state [(+dP/dt)/P] was similar in all groups. The data suggest that treatment of rats with CsA can induce a similar degree of fibrosis both in heterotopic cardiac transplants and in recipient native hearts without impairment of their contractile performance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kahan BD: Cyclosporine. N Engl J Med 321: 1725–1738, 1989

    PubMed  Google Scholar 

  2. Thomson AV, Whiting PH, Simpson JG: Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions 15: 306–327, 1984

    PubMed  Google Scholar 

  3. Billingham ME: Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1: 25–30, 1981

    Google Scholar 

  4. Stovin PGI, English TAH: Effects of cyclosporine on the transplanted human heart. J Heart Transplant 6: 180–185, 1987

    PubMed  Google Scholar 

  5. Tazelaar HD, Gay RE, Rowan RA, Billingham ME, Gay S: Collagen profile in the transplanted heart. Human Pathol 21: 424–428, 1990

    Google Scholar 

  6. Rovan RA, Billingham ME: Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis. Human Pathol 21: 767–772, 1990

    Google Scholar 

  7. Mottram PL, Mirisklavos A, Mason A, Dumble LJ, Smith JA, Chime GJA, Panagiotopoulos S, Nayler WG: Immunusuppressive and cardiotoxic effects of cyclosporine in CBA mice. Transplantation 48: 720–723, 1989

    PubMed  Google Scholar 

  8. Borland IA, Sells RA, Gosney JR, Beynon RJ: Strain-specific calcification of the heart in cyclosporine-treated mice. Transplant Proc 17: 1345–1348, 1985

    Google Scholar 

  9. Kishimoto C, Abelman WH: Absence of effects of cyclosporine on myocardial lymphocyte subsets in coxsackievirus B3 myocarditis in the aviremic stage. Circ Res 65: 934–945, 1989

    PubMed  Google Scholar 

  10. Owunwanne A, Shihab-Eldeen A, Sadek S, Junaid T, Yacoub T, Abdel Dayem HM: Is cyclosporine toxic to the heart? J Heart Lung Transplant 12: 199–204, 1993

    PubMed  Google Scholar 

  11. Kingma I, Harmsen E, ter Keurs HEDJ, Benediktsson H, Paul LC: Cyclosporine-associated reduction in systolic myocardial function in the rat. Int J Cardiol 31: 15–22, 1991

    Article  PubMed  Google Scholar 

  12. Cohen RG, Hoyt EG, Billingham ME, Bieber CP, Jamieson SW, Shumway N: Myocardial fibrosis due to cyclosporine in rat heterotopic heart transplantation. Heart Transplant 3: 355–358, 1984

    Google Scholar 

  13. Valantine HA, Appleton CP, Hatle LK, Hunt SA, Billingham ME, Shumway NE, Stinson EB, Popp RL: A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Circulation 79: 66–75, 1989

    PubMed  Google Scholar 

  14. Verani MS, George SE, Leon CA, Whisennand HH, Noon GP, Short HD, DeBakey ME, Young JB: Systolic and diastolic ventricular performance at rest and during exercise in heart transplant recipients. J Heart Transplant 7: 145–151, 1988

    PubMed  Google Scholar 

  15. Kolář F, MacNaughton C, Papoušek F, Korecky B: Systolic mechanical performance of heterotopically transplanted hearts in rats treated with cyclosporin. Cardiovasc Res 27: 1244–1247, 1993

    PubMed  Google Scholar 

  16. Banijamali HS, ter Keurs MH, Paul LC, ter Keurs HEDJ: Excitation contraction coupling in rat heart: influence of cyclosporin A. Cardiovasc Res 27: 1845–1854, 1993

    PubMed  Google Scholar 

  17. Hu S-J, Inselman G, Mohr K, Nellessen U: Lack of inotropic effect of cyclosporin A in isolated guinea pig left atria. Cardiovasc Res 27: 172–175, 1993

    PubMed  Google Scholar 

  18. Kolář F, Ošt'ádal B. Right ventricular function in rats with hypoxic pulmonary hypertension. Pflügers Arch 419: 121–126, 1991

    Google Scholar 

  19. Lee S, Willoughby WF, Smallwood CJ, Dawson A, Orlow MJ: Heterotopic heart and lung transplantation in the rat. Am J Pathol 59: 279–298, 1970

    PubMed  Google Scholar 

  20. Pelouch V, Dixon IM, Sethi R, Dhalla NS: Alteration of collagenous protein profile in congestive heart failure secondary to myocardial infarction. Mol Cell Biochem 129: 121–131, 1993

    PubMed  Google Scholar 

  21. Korecky B, Rakusan K: Morphological and physiological aspects of cardiac atrophy. In: NR Alpert (ed.) Perspectives in Cardiovascular Research: Myocardial Hypertrophy and Failure. Raven Press, New York, 1983, vol 7, pp 293–309

    Google Scholar 

  22. Weber KT, Brilla CG, Janicki JS: Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27: 341–348, 1993

    PubMed  Google Scholar 

  23. Shekonin B, Korecky B: Alterations of extracellular matrix in cardiac atrophy. In: B Ošt'ádal, NS Dhalla (eds). Heart Function in Health and Disease. Kluwer Acad Publishers, Boston, 1992, pp 321–335

    Google Scholar 

  24. Eleftheriades EG, Ferguson AG, Samarel AM: Cyclosporine A has no direct effect on collagen metabolism by cardiac fibroblasts in vitro. Circulation 86: 1368–1377, 1993

    Google Scholar 

  25. Ghiggeri GM, Altieri P, Oleggini R, Valenti F, Ginevri F, Perfumo F, Gusmano R: Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells ‘in culture.’ Different cell re sponses and phenotype characterization. Transplantation 57: 1382–1388, 1994

    PubMed  Google Scholar 

  26. Rego A, Vargas R, Cathapermal S, Kuwahara M, Foegh ML, Ramwell PW: Systemic vascular effects of cyclosporin A treatment in normotensive rats. J Pharmacol Exp Ther 259: 905–915, 1991

    PubMed  Google Scholar 

  27. Sturrock ND, Lang CC, Baylis PH, Struthers AD: Sequential effects of cyclosporine therapy on blood pressure, renal function and neurohormones. Kidney Int 45: 1203–1210, 1994

    PubMed  Google Scholar 

  28. Morgan BJ, Lyson T, Scherrer U, Victor RG: Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension 18: 458–466, 1991

    PubMed  Google Scholar 

  29. Shapiro AP, Rutan GH, Thomson ME, Nigalye RL: Hypertension following orthotopic cardiac transplantation. Cardiovasc Clin 20: 179–188, 1990

    PubMed  Google Scholar 

  30. Gillum DM, Truong L, Tasby J, Mighore P, Suki WN: Chronic cyclosporine nephrotoxicity. Transplantation 46: 285–292, 1988

    PubMed  Google Scholar 

  31. Weber KT, Sun Y, Tyagi SC, Cleutjens JPM: Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279–292, 1994

    Article  PubMed  Google Scholar 

  32. Julien J, Farge D, Kreft-Jais C, Guyene TT, Plouin PF, Houssin D, Carpentier A, Corvol P: Cyclosporine-induced stimulation of the reninangiotensin system after liver and heart transplantation. Transplantation 54: 885–891, 1993

    Google Scholar 

  33. Perico N, Zoja C, Benigni A, Ghilardi F, Gualandris L, Remuzzi G: Effect of short term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: Possible relevance to the reduction in glomerular filtration rate. J Pharmacol Exp Ther 129: 229–235, 1986

    Google Scholar 

  34. Andert SE, Feichtinger E, Grabenwoger M, Grimm M, Schreiner W, Muller MM: Cyclosporine A increases angiotensin-converting enzyme activity in heart transplant patients. Transplant Proc 25: 2735–2737, 1993

    PubMed  Google Scholar 

  35. Erman A, Chen-Gal B, Zabludowski J, Rosenfeld JB: Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 42: 525–527, 1990

    PubMed  Google Scholar 

  36. Iwai J, Kanayama Y, Inoue NN, Okamura M, Takeda T: Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats. Eur J Pharmacol 248: 341–344, 1993

    PubMed  Google Scholar 

  37. Iwai J, Kanayama Y, Negoro N, Inoue T, Okamura M, Takeda T: Increased gene expression of angiotensin II type 1A receptor in aortic smooth muscle cells of cyclosporine A-induced hypertensive rats. J Hypertens 11(suppl 5): S122-S123, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolář, F., Papoušek, F., MacNaughton, C. et al. Myocardial fibrosis and right ventricular function of heterotopically transplanted hearts in rats treated with cyclosporin. Mol Cell Biochem 163, 253–260 (1996). https://doi.org/10.1007/BF00408666

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00408666

Key words

Navigation